Importantly, lung cancer cells demonstrate a high level of resistance to complement-mediated lysis via activation of the classical pathway, as well as via the alternative pathway due to the role of CFH and FHL-1 [20]. This evidence concerns the gene FHL1 and lung carcinoma.